Carlos Gallardo

Carlos Gallardo is the Chief Executive Officer (CEO) of Almirall, a global biopharmaceutical company specializing in medical dermatology. He has been with Almirall since 2004 and has held various leadership roles, including Chairman of the Board of Directors. Gallardo's extensive experience in the pharmaceutical industry spans over 20 years, beginning with his tenure at Pfizer in New York.

Professional Background

• Education and Early Career: Carlos Gallardo began his career at Pfizer, where he gained valuable experience in sales and international operations.
• Almirall: He joined Almirall in 2004 and has since contributed significantly to the company's growth and strategic direction. Under his leadership, Almirall has focused on developing innovative treatments for skin conditions, leveraging advancements in drug discovery and a deep understanding of dermatological needs.

Leadership Role

• CEO Appointment: Gallardo was appointed as interim CEO on November 3, 2022, following the departure of Gianfranco Nazzi. His appointment was part of a transitional phase while the company sought a permanent successor.14
• Strategic Focus: He emphasizes collaboration within the healthcare community to enhance innovation in dermatology. His leadership aims to maintain Almirall's growth trajectory through continued investment in research and development.23

Vision for Almirall

Gallardo is committed to transforming Almirall into a leader in medical dermatology by addressing unmet medical needs and expanding the company's product offerings. His approach includes fostering partnerships and leveraging new technologies, such as artificial intelligence, to accelerate drug development.25

In summary, Carlos Gallardo is a seasoned executive with a robust background in the pharmaceutical industry, dedicated to advancing Almirall's mission to improve patient outcomes in dermatology.